Bright Path Laboratories
Bright Path Labs: Agile, scalable pharmaceutical manufacturing tech provider, addressing drug shortages and future health challenges.
Founded
2019Bright Path Labs: Agile, scalable pharmaceutical manufacturing tech provider, addressing drug shortages and future health challenges.
Bright Path Laboratories (BPL) is dedicated to revolutionizing pharmaceutical manufacturing with its agile and patented technology. The company focuses on rapid, low-cost, and scalable domestic production of active pharmaceutical ingredients (APIs), addressing critical gaps in the drug supply chain. BPL's mission is to ensure a sustainable and reliable supply of essential medicines, particularly in response to crises like the COVID-19 pandemic and future health challenges.
BPL has made significant strides in the pharmaceutical industry by leveraging its advanced manufacturing capabilities to produce APIs efficiently. This innovation not only reduces dependency on foreign suppliers but also mitigates the risks associated with supply chain disruptions. The company's impact is evident in its ability to provide timely solutions to drug shortages, thereby enhancing the resilience of the American healthcare system.
Companies similar to Bright Path Laboratories include Continuity Pharma, Resilience, Phlow and Brighton Biotech.
Bright Path Laboratories was founded in 2019.
Bright Path Laboratories' headquarters is located in Kannapolis, NC, US.
Bright Path Laboratories' most recent funding round was for $8.5M (USD) in November 2021.
As of Nov 18, 2021, Bright Path Laboratories has disclosed funding of $8.5M (USD). Undisclosed round amounts are excluded.
Bright Path Laboratories has 23 employees as of Feb 5, 2024.
Brighton Biotech
